 | • レポートコード：QY2108PAL8804 • 出版社/出版日：QYResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおけるデフェラシロクスの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、デフェラシロクスの種類別市場規模（500mg/錠、250mg/錠、125mg/錠、その他）、用途別市場規模（輸血鉄過剰症、NTDT鉄過剰症）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界のデフェラシロクス市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界におけるデフェラシロクスの種類別市場規模（2016年-2027年）：500mg/錠、250mg/錠、125mg/錠、その他 ・世界におけるデフェラシロクスの用途別市場規模（2016年-2027年）：輸血鉄過剰症、NTDT鉄過剰症 ・デフェラシロクスの中国市場分析 - デフェラシロクスの中国市場規模（2016年-2027年） - 中国におけるデフェラシロクスの主要プレイヤー別市場シェア - 中国におけるデフェラシロクスの種類別市場規模：500mg/錠、250mg/錠、125mg/錠、その他 - 中国におけるデフェラシロクスの用途別市場規模：輸血鉄過剰症、NTDT鉄過剰症 ・デフェラシロクスの北米市場（2016年-2027年） ・デフェラシロクスのヨーロッパ市場（2016年-2027年） ・デフェラシロクスのアジア太平洋市場（2016年-2027年） ・デフェラシロクスの中南米市場（2016年-2027年） ・デフェラシロクスの中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Novartis、Cipla、Natco Pharma、Sun Pharma ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias.
Deferasirox is marketed as Exjade, Desirox, Defrijet, Desifer, and Jadenu.
The half-life of deferasirox is between 8 and 16 hours allowing once a day dosing. Two molecules of deferasirox are capable of binding to 1 atom of iron which is subsequently eliminated by fecal excretion. Its low molecular weight and high lipophilicity allows the drug to be taken orally unlike deferoxamine which has to be administered by IV route (intravenous infusion). Together with deferiprone, deferasirox seems to be capable of removing iron from cells (cardiac myocytes and hepatocytes) as well as removing iron from the blood.
The major global manufacturers of Dillaros are Novartis, Cipla, Natco Pharma and Sun Pharma, among which Novartis is the industry leader with a market share of around 99%. North America is the largest spending region, with 30 per cent of the market, followed by Europe with 25 per cent.
Market Analysis and Insights: Global and China Deferasirox Market
This report focuses on global and China Deferasirox market.
In 2020, the global Deferasirox market size was US$ 2612.3 million and it is expected to reach US$ 3554.9 million by the end of 2027, with a CAGR of 4.5% during 2021-2027. In China the Deferasirox market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Deferasirox Scope and Market Size
Deferasirox market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Deferasirox market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Deferasirox market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
500 mg/Tablet
250 mg/Tablet
125 mg/Tablet
Others
Segment by Application
Transfusional Iron Overload
NTDT Caused Iron Overload
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Novartis
Cipla
Natco Pharma
Sun Pharma
1 Study Coverage
1.1 Deferasirox Product Introduction
1.2 Market by Type
1.2.1 Global Deferasirox Market Size Growth Rate by Type
1.2.2 500 mg/Tablet
1.2.3 250 mg/Tablet
1.2.4 125 mg/Tablet
1.2.5 Others
1.3 Market by Application
1.3.1 Global Deferasirox Market Size Growth Rate by Application
1.3.2 Transfusional Iron Overload
1.3.3 NTDT Caused Iron Overload
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Deferasirox Market Size, Estimates and Forecasts
2.1.1 Global Deferasirox Revenue 2016-2027
2.1.2 Global Deferasirox Sales 2016-2027
2.2 Global Deferasirox, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Deferasirox Historical Market Size by Region (2016-2021)
2.3.1 Global Deferasirox Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Deferasirox Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Deferasirox Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Deferasirox Sales Forecast by Region (2022-2027)
2.4.2 Global Deferasirox Revenue Forecast by Region (2022-2027)
3 Global Deferasirox Competitor Landscape by Players
3.1 Global Top Deferasirox Manufacturers by Sales
3.1.1 Global Deferasirox Sales by Manufacturer (2016-2021)
3.1.2 Global Deferasirox Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Deferasirox Manufacturers by Revenue
3.2.1 Key Deferasirox Manufacturers Covered: Ranking by Revenue
3.2.2 Global Deferasirox Revenue by Manufacturers (2016-2021)
3.2.3 Global Deferasirox Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Deferasirox Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Deferasirox Revenue in 2020
3.2.6 Global Deferasirox Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Deferasirox Price by Manufacturers
3.4 Global Deferasirox Manufacturing Base Distribution, Product Types
3.4.1 Deferasirox Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Deferasirox Product Type
3.4.3 Date of International Manufacturers Enter into Deferasirox Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Deferasirox Market Size by Type (2016-2021)
4.1.1 Global Deferasirox Sales by Type (2016-2021)
4.1.2 Global Deferasirox Revenue by Type (2016-2021)
4.1.3 Deferasirox Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Deferasirox Market Size Forecast by Type (2022-2027)
4.2.1 Global Deferasirox Sales Forecast by Type (2022-2027)
4.2.2 Global Deferasirox Revenue Forecast by Type (2022-2027)
4.2.3 Deferasirox Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Deferasirox Market Size by Application (2016-2021)
5.1.1 Global Deferasirox Sales by Application (2016-2021)
5.1.2 Global Deferasirox Revenue by Application (2016-2021)
5.1.3 Deferasirox Price by Application (2016-2021)
5.2 Deferasirox Market Size Forecast by Application (2022-2027)
5.2.1 Global Deferasirox Sales Forecast by Application (2022-2027)
5.2.2 Global Deferasirox Revenue Forecast by Application (2022-2027)
5.2.3 Global Deferasirox Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Deferasirox Market Size YoY Growth 2016-2027
6.1.1 China Deferasirox Sales YoY Growth 2016-2027
6.1.2 China Deferasirox Revenue YoY Growth 2016-2027
6.1.3 China Deferasirox Market Share in Global Market 2016-2027
6.2 China Deferasirox Market Size by Players (International and Local Players)
6.2.1 China Top Deferasirox Players by Sales (2016-2021)
6.2.2 China Top Deferasirox Players by Revenue (2016-2021)
6.3 China Deferasirox Historic Market Review by Type (2016-2021)
6.3.1 China Deferasirox Sales Market Share by Type (2016-2021)
6.3.2 China Deferasirox Revenue Market Share by Type (2016-2021)
6.3.3 China Deferasirox Price by Type (2016-2021)
6.4 China Deferasirox Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Deferasirox Sales Forecast by Type (2022-2027)
6.4.2 China Deferasirox Revenue Forecast by Type (2022-2027)
6.4.3 China Deferasirox Price Forecast by Type (2022-2027)
6.5 China Deferasirox Historic Market Review by Application (2016-2021)
6.5.1 China Deferasirox Sales Market Share by Application (2016-2021)
6.5.2 China Deferasirox Revenue Market Share by Application (2016-2021)
6.5.3 China Deferasirox Price by Application (2016-2021)
6.6 China Deferasirox Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Deferasirox Sales Forecast by Application (2022-2027)
6.6.2 China Deferasirox Revenue Forecast by Application (2022-2027)
6.6.3 China Deferasirox Price Forecast by Application (2022-2027)
7 North America
7.1 North America Deferasirox Market Size YoY Growth 2016-2027
7.2 North America Deferasirox Market Facts & Figures by Country
7.2.1 North America Deferasirox Sales by Country (2016-2021)
7.2.2 North America Deferasirox Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Deferasirox Market Size YoY Growth 2016-2027
8.2 Asia Pacific Deferasirox Market Facts & Figures by Region
8.2.1 Asia Pacific Deferasirox Sales by Region (2016-2021)
8.2.2 Asia Pacific Deferasirox Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Deferasirox Market Size YoY Growth 2016-2027
9.2 Europe Deferasirox Market Facts & Figures by Country
9.2.1 Europe Deferasirox Sales by Country (2016-2021)
9.2.2 Europe Deferasirox Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Deferasirox Market Size YoY Growth 2016-2027
10.2 Latin America Deferasirox Market Facts & Figures by Country
10.2.1 Latin America Deferasirox Sales by Country (2016-2021)
10.2.2 Latin America Deferasirox Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Deferasirox Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Deferasirox Market Facts & Figures by Country
11.2.1 Middle East and Africa Deferasirox Sales by Country (2016-2021)
11.2.2 Middle East and Africa Deferasirox Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Deferasirox Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Deferasirox Products Offered
12.1.5 Novartis Recent Development
12.2 Cipla
12.2.1 Cipla Corporation Information
12.2.2 Cipla Description and Business Overview
12.2.3 Cipla Deferasirox Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Cipla Deferasirox Products Offered
12.2.5 Cipla Recent Development
12.3 Natco Pharma
12.3.1 Natco Pharma Corporation Information
12.3.2 Natco Pharma Description and Business Overview
12.3.3 Natco Pharma Deferasirox Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Natco Pharma Deferasirox Products Offered
12.3.5 Natco Pharma Recent Development
12.4 Sun Pharma
12.4.1 Sun Pharma Corporation Information
12.4.2 Sun Pharma Description and Business Overview
12.4.3 Sun Pharma Deferasirox Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sun Pharma Deferasirox Products Offered
12.4.5 Sun Pharma Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Deferasirox Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novartis Deferasirox Products Offered
12.11.5 Novartis Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Deferasirox Industry Trends
13.2 Deferasirox Market Drivers
13.3 Deferasirox Market Challenges
13.4 Deferasirox Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Deferasirox Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Deferasirox Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 500 mg/Tablet
Table 3. Major Manufacturers of 250 mg/Tablet
Table 4. Major Manufacturers of 125 mg/Tablet
Table 5. Major Manufacturers of Others
Table 6. Global Deferasirox Market Size Growth Rate by Application (2021-2027) & (M Tablets)
Table 7. Global Deferasirox Market Size by Region (M Tablets) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Deferasirox Sales by Regions (2016-2021) & (M Tablets)
Table 9. Global Deferasirox Sales Market Share by Regions (2016-2021)
Table 10. Global Deferasirox Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Deferasirox Sales Forecast by Region (2022-2027) & (M Tablets)
Table 12. Global Deferasirox Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Deferasirox Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Deferasirox Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Deferasirox Sales by Manufacturers (2016-2021) (M Tablets)
Table 16. Global Deferasirox Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Deferasirox Manufacturers by Revenue (US$ Million) in 2020
Table 18. Deferasirox Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Deferasirox Revenue Share by Manufacturers (2016-2021)
Table 20. Global Deferasirox Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Deferasirox by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Deferasirox as of 2020)
Table 22. Key Manufacturers Deferasirox Price (2016-2021) (USD/Tablet)
Table 23. Deferasirox Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Deferasirox Product Type
Table 25. Date of International Manufacturers Enter into Deferasirox Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Deferasirox Sales by Type (2016-2021) (M Tablets)
Table 28. Global Deferasirox Sales Share by Type (2016-2021)
Table 29. Global Deferasirox Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Deferasirox Revenue Share by Type (2016-2021)
Table 31. Deferasirox Average Selling Price (ASP) by Type (2016-2021) & (USD/Tablet)
Table 32. Global Deferasirox Sales Forecast by Type (2022-2027) & (M Tablets)
Table 33. Global Deferasirox Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Deferasirox Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Deferasirox Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Deferasirox Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Tablet)
Table 37. Global Deferasirox Sales by Application (2016-2021) (M Tablets)
Table 38. Global Deferasirox Sales Share by Application (2016-2021)
Table 39. Global Deferasirox Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Deferasirox Revenue Share by Application (2016-2021)
Table 41. Deferasirox Average Selling Price (ASP) by Application (2016-2021) & (USD/Tablet)
Table 42. Global Deferasirox Sales Forecast by Application (2022-2027) & (M Tablets)
Table 43. Global Deferasirox Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Deferasirox Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Deferasirox Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Deferasirox Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Tablet)
Table 47. China Deferasirox Sales (M Tablets) of Key Companies (2016-2021)
Table 48. China Deferasirox Sales Share by Company (2016-2021)
Table 49. China Deferasirox Revenue (US$ Million) by Company (2016-2021)
Table 50. China Deferasirox Revenue Share by Company (2016-2021)
Table 51. China Deferasirox Sales (M Tablets) by Type (2016-2021)
Table 52. China Deferasirox Sales Share by Type (2016-2021)
Table 53. China Deferasirox Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. China Deferasirox Price (USD/Tablet) by Type (2016-2021)
Table 55. China Deferasirox Sales (M Tablets) by Type (2022-2027)
Table 56. China Deferasirox Sales Share by Type (2022-2027)
Table 57. China Deferasirox Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. China Deferasirox Revenue Share by Type (2022-2027)
Table 59. China Deferasirox Price (USD/Tablet) by Type (2022-2027)
Table 60. China Deferasirox Sales (M Tablets) by Application (2016-2021)
Table 61. China Deferasirox Sales Share by Application (2016-2021)
Table 62. China Deferasirox Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. China Deferasirox Price (USD/Tablet) by Application (2016-2021)
Table 64. China Deferasirox Sales (M Tablets) by Application (2022-2027)
Table 65. China Deferasirox Sales Share by Application (2022-2027)
Table 66. China Deferasirox Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. China Deferasirox Revenue Share by Application (2022-2027)
Table 68. China Deferasirox Price (USD/Tablet) by Application (2022-2027)
Table 69. North America Deferasirox Sales by Country (2016-2021) & (M Tablets)
Table 70. North America Deferasirox Sales Market Share by Country (2016-2021)
Table 71. North America Deferasirox Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Deferasirox Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Deferasirox Sales by Region (2016-2021) & (M Tablets)
Table 74. Asia Pacific Deferasirox Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Deferasirox Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Deferasirox Revenue Market Share by Region (2016-2021)
Table 77. Europe Deferasirox Sales by Country (2016-2021) & (M Tablets)
Table 78. Europe Deferasirox Sales Market Share by Country (2016-2021)
Table 79. Europe Deferasirox Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Deferasirox Revenue Market Share by Country (2016-2021)
Table 81. Latin America Deferasirox Sales by Country (2016-2021) & (M Tablets)
Table 82. Latin America Deferasirox Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Deferasirox Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Deferasirox Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Deferasirox Sales by Country (2016-2021) & (M Tablets)
Table 86. Middle East and Africa Deferasirox Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Deferasirox Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Deferasirox Revenue Market Share by Country (2016-2021)
Table 89. Novartis Corporation Information
Table 90. Novartis Description and Business Overview
Table 91. Novartis Deferasirox Sales (M Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 92. Novartis Deferasirox Product
Table 93. Novartis Recent Development
Table 94. Cipla Corporation Information
Table 95. Cipla Description and Business Overview
Table 96. Cipla Deferasirox Sales (M Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 97. Cipla Product
Table 98. Cipla Recent Development
Table 99. Natco Pharma Corporation Information
Table 100. Natco Pharma Description and Business Overview
Table 101. Natco Pharma Deferasirox Sales (M Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 102. Natco Pharma Product
Table 103. Natco Pharma Recent Development
Table 104. Sun Pharma Corporation Information
Table 105. Sun Pharma Description and Business Overview
Table 106. Sun Pharma Deferasirox Sales (M Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2016-2021)
Table 107. Sun Pharma Product
Table 108. Sun Pharma Recent Development
Table 109. Deferasirox Market Trends
Table 110. Deferasirox Market Drivers
Table 111. Deferasirox Market Challenges
Table 112. Deferasirox Market Restraints
Table 113. Deferasirox Customers List
Table 114. Deferasirox Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Deferasirox Product Picture
Figure 2. Global Deferasirox Sales Market Share by Type in 2020 & 2027
Figure 3. 500 mg/Tablet Product Picture
Figure 4. 250 mg/Tablet Product Picture
Figure 5. 125 mg/Tablet Product Picture
Figure 6. Others Product Picture
Figure 7. Global Deferasirox Sales Market Share by Application in 2020 & 2027
Figure 8. Transfusional Iron Overload
Figure 9. NTDT Caused Iron Overload
Figure 10. Deferasirox Report Years Considered
Figure 11. Global Deferasirox Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Deferasirox Market Size 2016-2027 (US$ Million)
Figure 13. Global Deferasirox Sales 2016-2027 (M Tablets)
Figure 14. Global Deferasirox Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Deferasirox Sales Market Share by Region (2016-2021)
Figure 16. Global Deferasirox Sales Market Share by Region in 2020
Figure 17. Global Deferasirox Revenue Market Share by Region (2016-2021)
Figure 18. Global Deferasirox Revenue Market Share by Region in 2020
Figure 19. Global Deferasirox Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Deferasirox Revenue in 2020
Figure 21. Deferasirox Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Deferasirox Sales Market Share by Type (2016-2021)
Figure 23. Global Deferasirox Sales Market Share by Type in 2020
Figure 24. Global Deferasirox Revenue Market Share by Type (2016-2021)
Figure 25. Global Deferasirox Revenue Market Share by Type in 2020
Figure 26. Global Deferasirox Sales Market Share by Application (2016-2021)
Figure 27. Global Deferasirox Sales Market Share by Application in 2020
Figure 28. Global Deferasirox Revenue Market Share by Application (2016-2021)
Figure 29. Global Deferasirox Revenue Market Share by Application in 2020
Figure 30. China Deferasirox Sales Growth Rate 2016-2027 (M Tablets)
Figure 31. China Deferasirox Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. China Deferasirox Market Share in Global Market 2016-2027
Figure 33. China 5 and 10 Largest Deferasirox Players Market Share by Revenue in Deferasirox in 2020
Figure 34. China Deferasirox Revenue Share by Type (2016-2021)
Figure 35. China Deferasirox Revenue Growth Rate by Type in 2016 & 2020
Figure 36. China Deferasirox Revenue Share by Application (2016-2021)
Figure 37. China Deferasirox Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Deferasirox Sales Growth Rate 2016-2021 (M Tablets)
Figure 39. North America Deferasirox Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Deferasirox Sales Market Share by Country in 2020
Figure 41. North America Deferasirox Revenue Market Share by Country in 2020
Figure 42. U.S. Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 43. U.S. Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 45. Canada Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Deferasirox Sales Growth Rate 2016-2021 (M Tablets)
Figure 47. Europe Deferasirox Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Deferasirox Sales Market Share by Country in 2020
Figure 49. Europe Deferasirox Revenue Market Share by Country in 2020
Figure 50. Germany Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 51. Germany Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 53. France Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 55. U.K. Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 57. Italy Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 59. Russia Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Deferasirox Sales Growth Rate 2016-2021 (M Tablets)
Figure 61. Asia Pacific Deferasirox Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Deferasirox Sales Market Share by Region in 2020
Figure 63. Asia Pacific Deferasirox Revenue Market Share by Region in 2020
Figure 64. China Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 65. China Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 67. Japan Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 69. South Korea Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 71. India Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 73. Australia Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Taiwan Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 75. Taiwan Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 77. Indonesia Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 79. Thailand Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 81. Malaysia Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Philippines Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 83. Philippines Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Vietnam Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 85. Vietnam Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Latin America Deferasirox Sales Growth Rate 2016-2021 (M Tablets)
Figure 87. Latin America Deferasirox Revenue Growth Rate 2016-2021 (US$ Million)
Figure 88. Latin America Deferasirox Sales Market Share by Country in 2020
Figure 89. Latin America Deferasirox Revenue Market Share by Country in 2020
Figure 90. Mexico Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 91. Mexico Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Brazil Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 93. Brazil Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Argentina Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 95. Argentina Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Middle East and Africa Deferasirox Sales Growth Rate 2016-2021 (M Tablets)
Figure 97. Middle East and Africa Deferasirox Revenue Growth Rate 2016-2021 (US$ Million)
Figure 98. Middle East and Africa Deferasirox Sales Market Share by Country in 2020
Figure 99. Middle East and Africa Deferasirox Revenue Market Share by Country in 2020
Figure 100. Turkey Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 101. Turkey Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Saudi Arabia Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 103. Saudi Arabia Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. U.A.E Deferasirox Sales Growth Rate (2016-2021) (M Tablets)
Figure 105. U.A.E Deferasirox Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Deferasirox Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
世界のデフェラシロクスAPI市場インサイト・予測（～2027年） Deferasirox is a synthetic, orally bioavailable, achiral, tridentate triazole derived from salicylic acid with iron-chelating activity. Deferasirox chelates iron at a 2:1 (ligand:iron) ratio. Because of its oral availability and long plasma half-life, this agent may be superior to desferrioxamine (d…- 鉄キレート剤の世界市場 2020年 Market Overview The Iron Chelation Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界の過負荷クラッチ市場インサイト・予測（～2027年） Market Analysis and Insights: Global Overload Clutche Market The global Overload Clutche market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Overload Clutche Scope and Segment Overload Clutche mar…
- 世界の過負荷クラッチ市場インサイト・予測（～2027年） Market Analysis and Insights: Global Overload Clutche Market The global Overload Clutche market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Overload Clutche Scope and Segment Overload Clutche mar…
- タブレット用キーボードの世界及び中国市場 Tablet keyboard, usually used for 2-in-1 tablet, is a typewriter-style device which uses an arrangement of buttons or keys to act as mechanical levers or electronic switches. A 2-in-1 tablet is a portable computer that shares characteristics of both tablets and laptops. Before the emergence of 2-in-…